Management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Update ACC/AHA guidelines

American Journal of Emergency Medicine

Volumn 21, Issue 4, 2003, Pages 346-351

  Ornato, Joseph P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM SULFATE; NICOTINIC ACID; NITRATE; PLACEBO; POTASSIUM CHLORIDE; THIENO[3,2 C]PYRIDINE DERIVATIVE; TICLOPIDINE; TINZAPARIN; TIROFIBAN;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ELECTROCARDIOGRAM; EXERCISE TEST; HEART INFARCTION; HEART REHABILITATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; SMOKING CESSATION; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; WEIGHT REDUCTION;

EID: 0042574181     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(03)00028-7     Document Type: Article

References (21)

1. American College of Cardiology: Practice guidelines update: Unstable angina/non-ST elevation myocardial infarction. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. ACC Web site. Available from URL: http://www.acc.org. Accessed October 29, 2002
2. Braunwald E, ACC/AHA Committee on the Management of Patients With Unstable Angina: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-Summary article. J Am Coll Card 2002;40:1366-1374
3. Pollack CV Jr, Gibler WB: Advances create opportunities: Implementing the major tenets of the new unstable angina guidelines in the emergency department. Ann Emerg Med 2001;38:241-248
4. Pollack CV Jr, Gibler WB: 2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A practical summary for emergency physicians. Ann Emerg Med 2001;38:229-240
5. Antman EM, Cohen M, Bernink PJ, et al: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-842
6. Cohen M, Demers C, Gurfinkel EP, et al: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997;337:447-452
7. Morrow DA, Antman EM, Snapinn SM, et al: An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: Application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002;23:223-229
8. Cannon CP, Weintraub WS, Demopoulos LA, et al: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887
9. Yusuf S, Zhao F, Mehta SR, et al: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
10. Mehta SR, Yusuf S, Peters RJ, et al: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-533
11. Budaj A, Yusuf S, Mehta SR, et al: Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002;106:1622-1626
12. Steinhubl SR, Berger PB, Mann JT, et al: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002;288:2411-2420
13. The ESPRIT Investigators: Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial. Lancet 2000;356:2037-2044
14. Topol EJ, Moliterno DJ, Herrmann HC, et al: Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001;344:1888-1894
15. The PRISM-PLUS (Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Study Investigators: Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-1497
16. The PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy) Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339: 436-443
17. Simoons ML: Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: The GUSTO IV-ACS randomized trial. Lancet 2001;357:1915-1924
18. Michalis LK, Papamichail N, Katsouras CS: Enoxaparin versus Tinzaparin in the management of unstable coronary artery disease (EVET study). J Am Coll Card 101 2001;37:365a. Abstract 1253-95 (suppl)
19. Morrow DA, Cannon CP, Rifai N, et al: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial. JAMA 2001; 286:2405-2412
20. Schwartz GG, Olsson AG, Ezekowitz MD, et al: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: a randomized controlled trial. JAMA 2001;285:1711-1718
21. Fonarow GC, Gawlinski A, Moughrabi S, et al: Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-822